# Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM)

> **NCT00480194** · — · COMPLETED · sponsor: **Nycomed** · enrollment: 1000 (estimated)

## Conditions studied

- Common Cold

## Interventions

- **DRUG:** xylometazoline hydrochloride and ipratropium bromide (ZyComb)

## Key facts

- **NCT ID:** NCT00480194
- **Lead sponsor:** Nycomed
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2012-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00480194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00480194, "Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00480194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*